Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amino Acids, Branched-Chain | 1 | 2023 | 249 | 0.730 |
Why?
|
| Diet, Mediterranean | 1 | 2023 | 696 | 0.580 |
Why?
|
| Foramen Ovale, Patent | 1 | 2018 | 223 | 0.510 |
Why?
|
| Tricuspid Valve | 1 | 2016 | 400 | 0.450 |
Why?
|
| Endocarditis | 1 | 2016 | 348 | 0.410 |
Why?
|
| Allied Health Personnel | 1 | 2013 | 162 | 0.410 |
Why?
|
| Thromboembolism | 1 | 2018 | 983 | 0.400 |
Why?
|
| Proteomics | 2 | 2023 | 3618 | 0.380 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 2043 | 0.320 |
Why?
|
| Placebos | 1 | 2013 | 1677 | 0.320 |
Why?
|
| Medical Records | 1 | 2013 | 1413 | 0.300 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 1348 | 0.300 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 2566 | 0.300 |
Why?
|
| Echocardiography | 2 | 2016 | 5097 | 0.290 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2005 | 88 | 0.270 |
Why?
|
| Gene Products, tat | 1 | 2005 | 120 | 0.270 |
Why?
|
| Sepsis | 1 | 2019 | 2589 | 0.250 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5724 | 0.240 |
Why?
|
| Orthopedics | 1 | 2013 | 903 | 0.240 |
Why?
|
| Persea | 1 | 2023 | 17 | 0.230 |
Why?
|
| Exercise | 3 | 2023 | 5611 | 0.220 |
Why?
|
| Hospital Mortality | 1 | 2016 | 5310 | 0.210 |
Why?
|
| Secondary Prevention | 2 | 2018 | 1520 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7153 | 0.190 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 2012 | 279 | 0.170 |
Why?
|
| Blood Proteins | 1 | 2023 | 1122 | 0.160 |
Why?
|
| Hypertension | 1 | 2018 | 8455 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2013 | 3306 | 0.150 |
Why?
|
| Virus Replication | 1 | 2005 | 2531 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15108 | 0.150 |
Why?
|
| Melanoma, Experimental | 2 | 2012 | 559 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 7901 | 0.140 |
Why?
|
| Research Design | 1 | 2013 | 5979 | 0.140 |
Why?
|
| Metabolome | 1 | 2023 | 881 | 0.140 |
Why?
|
| RNA | 1 | 2005 | 2747 | 0.130 |
Why?
|
| Stroke | 1 | 2018 | 9963 | 0.130 |
Why?
|
| Kinetics | 1 | 2023 | 6474 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 11695 | 0.130 |
Why?
|
| Peptide Fragments | 2 | 2012 | 5095 | 0.120 |
Why?
|
| Genetic Vectors | 4 | 2012 | 3420 | 0.120 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2012 | 305 | 0.110 |
Why?
|
| Cancer Vaccines | 2 | 2012 | 1021 | 0.110 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 431 | 0.110 |
Why?
|
| Humans | 18 | 2023 | 742088 | 0.090 |
Why?
|
| Health Status | 1 | 2023 | 4030 | 0.090 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 4250 | 0.090 |
Why?
|
| Risk Factors | 5 | 2023 | 72145 | 0.090 |
Why?
|
| Hepatitis B Vaccines | 1 | 2011 | 194 | 0.090 |
Why?
|
| Middle Aged | 7 | 2023 | 213127 | 0.090 |
Why?
|
| Sample Size | 1 | 2013 | 844 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2023 | 3861 | 0.090 |
Why?
|
| I-kappa B Kinase | 1 | 2010 | 251 | 0.080 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 2161 | 0.080 |
Why?
|
| Male | 9 | 2023 | 349538 | 0.080 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2010 | 256 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3428 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2018 | 1472 | 0.070 |
Why?
|
| Observer Variation | 1 | 2013 | 2593 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2009 | 424 | 0.070 |
Why?
|
| Hepatitis B, Chronic | 1 | 2011 | 393 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2016 | 2266 | 0.070 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2005 | 127 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6534 | 0.070 |
Why?
|
| Dependovirus | 1 | 2010 | 706 | 0.060 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 2337 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 19862 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 12220 | 0.060 |
Why?
|
| Massachusetts | 2 | 2016 | 8662 | 0.060 |
Why?
|
| Lentivirus | 3 | 2012 | 501 | 0.060 |
Why?
|
| Obesity | 2 | 2023 | 12705 | 0.060 |
Why?
|
| Reoperation | 1 | 2013 | 4200 | 0.060 |
Why?
|
| Aged | 5 | 2023 | 162944 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2714 | 0.060 |
Why?
|
| Adult | 4 | 2023 | 213712 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2018 | 4595 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 913 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2018 | 8541 | 0.050 |
Why?
|
| Female | 7 | 2023 | 379592 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2645 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2013 | 1457 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2010 | 2500 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 292 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2009 | 1983 | 0.050 |
Why?
|
| Glucose | 2 | 2023 | 4391 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2012 | 5519 | 0.050 |
Why?
|
| Physical Endurance | 1 | 2023 | 370 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 10943 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 4379 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2013 | 6191 | 0.040 |
Why?
|
| Insulin | 2 | 2023 | 6575 | 0.040 |
Why?
|
| HIV | 1 | 2005 | 1600 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 3769 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2023 | 1869 | 0.040 |
Why?
|
| Binding Sites | 1 | 2005 | 6115 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 4438 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2011 | 4414 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 4933 | 0.030 |
Why?
|
| Genome | 1 | 2023 | 1803 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 10856 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 5867 | 0.030 |
Why?
|
| Homeostasis | 1 | 2023 | 3335 | 0.030 |
Why?
|
| Cell Line | 1 | 2005 | 15994 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15244 | 0.020 |
Why?
|
| Mice, Inbred mdx | 1 | 2010 | 90 | 0.020 |
Why?
|
| Hepatitis B Antibodies | 1 | 2011 | 159 | 0.020 |
Why?
|
| Mice | 5 | 2023 | 81045 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 21821 | 0.020 |
Why?
|
| Outpatients | 1 | 2016 | 1483 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2023 | 6249 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2011 | 633 | 0.020 |
Why?
|
| Cause of Death | 1 | 2018 | 3571 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 77098 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2749 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16331 | 0.020 |
Why?
|
| Animals | 5 | 2023 | 168561 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2009 | 880 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 1224 | 0.020 |
Why?
|
| Autoantigens | 1 | 2009 | 891 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 2505 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12017 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2009 | 1038 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2018 | 53187 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4200 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 24913 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 3770 | 0.010 |
Why?
|
| Regeneration | 1 | 2010 | 1485 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2010 | 2968 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20928 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5975 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 2986 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9735 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14554 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39004 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 10163 | 0.010 |
Why?
|
| Inflammation | 1 | 2012 | 10578 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 62966 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18006 | 0.010 |
Why?
|
| United States | 1 | 2018 | 69693 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13655 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 23387 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 29717 | 0.000 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_